19 May 2013
Keywords: allelix, alx1-11, phase, ii, preliminary, results, biopharmaceuticals
Article | 23 October 1998
Allelix Biopharmaceuticals has announced the results of its Phase IItrial with ALX1-11 (human parathyroid hormone 1-84) in patients with ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.